|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-4498 |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...UAACUGCCCCACAU
CCAGCCCA
... 3' GUCGUGAACGGGAC GGUCGGG U |
8mer | 3613-3620 | -0.292 | 92.0 | -0.292 | 94.0 | noncon | |
5'...AUAAACUCUUCAGU
CCAGCCCA
... 3' GUCGUGAACGGGAC GGUCGGG U |
8mer | 8651-8658 | -0.279 | 91.0 | -0.279 | 93.0 | noncon | |
5'...AUACACGCCUACAC
CCAGCCC
C... 3' GUCGUGAACGGGAC GGUCGGG U |
7mer-m8 | 2816-2822 | -0.161 | 73.0 | -0.161 | 80.0 | noncon | |
5'...CAAGUGUCCAAUGG
CAGCCCA
A... 3' GUCGUGAACGGGACG GUCGGG U |
7mer-A1 | 8608-8614 | -0.154 | 71.0 | -0.154 | 79.0 | noncon | |
5'...CUGUCCUGCCCUGG
CCAGCCC
U... 3' GUCGUGAACGGGAC GGUCGGG U |
7mer-m8 | 8572-8578 | -0.14 | 68.0 | -0.14 | 76.0 | noncon | |
5'...ACAGCAUCAGCUCA
CAGCCCA
C... 3' GUCGUGAACGGGACG GUCGGG U |
7mer-A1 | 1854-1860 | -0.137 | 67.0 | -0.137 | 76.0 | noncon | |
5'...UAGGAAGCUUGGGA
CCAGCCC
U... 3' GUCGUGAACGGGAC GGUCGGG U |
7mer-m8 | 8377-8383 | -0.114 | 62.0 | -0.114 | 71.0 | noncon | |
5'...UGUGCGCCUGUCCU
CCAGCCC
G... 3' GUCGUGAACGGGAC GGUCGGG U |
7mer-m8 | 4758-4764 | -0.091 | 55.0 | -0.091 | 67.0 | noncon | |
5'...UCCGCCUCCGGGUU
CCAGCCC
U... 3' GUCGUGAACGGGAC GGUCGGG U |
7mer-m8 | 6369-6375 | -0.043 | 39.0 | -0.043 | 53.0 | noncon |